Anastrozole IP CAS NO. 120511-73-1 (Purity 99%)

Anastrozole is a non-steroidal, selective aromatase inhibitor widely used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It acts by inhibiting the aromatase enzyme responsible for converting androgens into estrogens, thereby significantly lowering circulating estrogen levels and reducing the stimulation of estrogen-dependent tumor growth. Anastrozole is commonly prescribed as adjuvant therapy, first-line treatment for advanced breast cancer, and as extended therapy following tamoxifen. Due to its efficacy, oral convenience, and favorable safety profile, anastrozole is a key agent in endocrine cancer therapy. Synonyms: Arimidex, Anastrozol, Anastrozolum, ZD-1033. About the Company GST Registration Date: 2022 Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 1.5 - 5 Cr company-description: Incepted in the year 2022, "AVD Pharmaceuticals Private Limited" is distinguished API Intermidate Manufacture, Impurities, Fine chemical, Contract reserch, API Manufacture , Custom Synthises, Reserch and Development, And Pharamacitical Drug Product, and Importar-Exporter Trader, offering an enormous consignment and etc.